AMGEN INC. 2024-2025 Proxy Voting Records

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. Austin

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Wanda M. Austin”): 399,241,184 for, 4,695,034 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 229 asset managers below reported 178,877,666 for, 403,590 against, 27,734 abstained, 2,512 unknown.

Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Bradway

AMGEN INC.’s own tally for this item (“Elect Director: Mr. Robert A. Bradway”): 375,676,872 for, 26,441,785 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 229 asset managers below reported 179,074,916 for, 207,586 against, 27,737 abstained, 1,263 unknown.

Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. Drake

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Michael V. Drake”): 399,379,212 for, 4,268,118 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 229 asset managers below reported 179,013,461 for, 256,963 against, 40,076 abstained, 1,002 unknown.

Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. Druker

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Brian J. Druker”): 399,421,475 for, 4,481,785 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 229 asset managers below reported 178,874,003 for, 407,250 against, 27,736 abstained, 2,512 unknown.

Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Eckert

AMGEN INC.’s own tally for this item (“Elect Director: Mr. Robert A. Eckert”): 381,713,097 for, 21,605,957 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 229 asset managers below reported 178,283,083 for, 998,129 against, 27,778 abstained, 2,512 unknown.

Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. Garland

AMGEN INC.’s own tally for this item (“Elect Director: Mr. Greg C. Garland”): 384,198,583 for, 19,699,619 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 229 asset managers below reported 178,382,671 for, 898,583 against, 27,737 abstained, 2,512 unknown.

Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr.

AMGEN INC.’s own tally for this item (“Elect Director: Mr. Charles M. Holley, Jr.”): 396,883,070 for, 7,000,392 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 229 asset managers below reported 179,015,273 for, 267,490 against, 27,738 abstained, 1,002 unknown.

Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar Ishrak

AMGEN INC.’s own tally for this item (“Elect Director: Dr. S. Omar Ishrak”): 398,671,821 for, 5,218,699 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 229 asset managers below reported 178,874,077 for, 407,176 against, 27,737 abstained, 2,512 unknown.

Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler Jacks

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Tyler Jacks”): 392,818,616 for, 10,591,022 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 229 asset managers below reported 178,742,628 for, 538,590 against, 27,771 abstained, 2,512 unknown.

Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. Klotman

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Mary E. Klotman”): 400,133,252 for, 3,547,127 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 229 asset managers below reported 179,245,759 for, 24,668 against, 40,073 abstained, 1,002 unknown.

Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. Kullman

AMGEN INC.’s own tally for this item (“Elect Director: Ms. Ellen J. Kullman”): 399,256,857 for, 4,429,859 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 229 asset managers below reported 179,013,412 for, 269,336 against, 27,752 abstained, 1,002 unknown.

Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. Miles

AMGEN INC.’s own tally for this item (“Elect Director: Ms. Amy E. Miles”): 399,556,351 for, 4,116,751 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 229 asset managers below reported 179,016,200 for, 266,548 against, 27,753 abstained, 1,002 unknown.

Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.

Description as filed by funds: Advisory vote to approve our executive compensation.

AMGEN INC.’s own tally for this item (“2. Advisor y Vote to A pprove Our Executive Compensation The advisory vote to approve our executive compensation”): 381,269,281 for, 21,382,050 against — passed, per its Form 8-K filed May 27, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Item 2 - Advisor y Vote to A pprove Our Executive Compensation The advisory vote to approve our executive compensation was approved.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of AMGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (57 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “SECTION 14A SAY-ON-PAY VOTES” (3 managers, 28,133 for); “COMPENSATION” (2 managers, 4,247 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 207 managers: 177,354,086 for, 1,175,067 against, 2,151 withheld, 42,820 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 1,255 managers: 208,460,006 for, 12,408,589 against, 20,913 abstained, 63,571 not voted, 23,203 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2025.

AMGEN INC.’s own tally for this item (“3. Ratification of Selection of Inde pendent Re gistered Public Accountants Ernst & Young LLP”): 441,615,581 for, 26,675,877 against — passed, per its Form 8-K filed May 27, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Item 3 - Ratification of Selection of Inde pendent Re gistered Public Accountants Ernst & Young LLP was ratified as the Company's independent registered public accountants for the fiscal year ending December 31, 2025.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of AMGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (9 managers, 39,899 for, 232,997 against).

The 229 asset managers below reported 177,845,600 for, 1,182,682 against, 27,728 abstained, 1,510 unknown.

Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.